These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 36196977)

  • 1. Natural product-based PROteolysis TArgeting Chimeras (PROTACs).
    Liu M; Martyn AP; Quinn RJ
    Nat Prod Rep; 2022 Dec; 39(12):2292-2307. PubMed ID: 36196977
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proteolysis targeting chimeras (PROTACs) in 'beyond rule-of-five' chemical space: Recent progress and future challenges.
    Edmondson SD; Yang B; Fallan C
    Bioorg Med Chem Lett; 2019 Jul; 29(13):1555-1564. PubMed ID: 31047748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Accelerating PROTACs Discovery Through a Direct-to-Biology Platform Enabled by Modular Photoclick Chemistry.
    Yan KN; Nie YQ; Wang JY; Yin GL; Liu Q; Hu H; Sun X; Chen XH
    Adv Sci (Weinh); 2024 Jul; 11(26):e2400594. PubMed ID: 38689503
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-PROTACs: state of the art and perspectives.
    Zhong J; Zhao R; Wang Y; Su YX; Lan X
    Nanoscale; 2024 Feb; 16(9):4378-4391. PubMed ID: 38305466
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advances and perspectives of proteolysis targeting chimeras (PROTACs) in drug discovery.
    Xi JY; Zhang RY; Chen K; Yao L; Li MQ; Jiang R; Li XY; Fan L
    Bioorg Chem; 2022 Aug; 125():105848. PubMed ID: 35533582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug delivery challenges and formulation aspects of proteolysis targeting chimera (PROTACs).
    Saraswat AL; Vartak R; Hegazy R; Patel A; Patel K
    Drug Discov Today; 2023 Jan; 28(1):103387. PubMed ID: 36184017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ternary Complex-Templated Dynamic Combinatorial Chemistry for the Selection and Identification of Homo-PROTACs.
    Diehl CJ; Salerno A; Ciulli A
    Angew Chem Int Ed Engl; 2024 Jun; 63(25):e202319456. PubMed ID: 38626385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Use of ionic liquids in amidation reactions for proteolysis targeting chimera synthesis.
    Eleuteri M; Desantis J; Cruciani G; Germani R; Goracci L
    Org Biomol Chem; 2024 May; 22(17):3477-3489. PubMed ID: 38602033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enriching Proteolysis Targeting Chimeras with a Second Modality: When Two Are Better Than One.
    Salerno A; Seghetti F; Caciolla J; Uliassi E; Testi E; Guardigni M; Roberti M; Milelli A; Bolognesi ML
    J Med Chem; 2022 Jul; 65(14):9507-9530. PubMed ID: 35816671
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteolysis Targeting Chimeras (PROTACs) based on celastrol induce multiple protein degradation for triple-negative breast cancer treatment.
    Gan X; Wang F; Luo J; Zhao Y; Wang Y; Yu C; Chen J
    Eur J Pharm Sci; 2024 Jan; 192():106624. PubMed ID: 37898394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Strategies for designing proteolysis targeting chimaeras (PROTACs).
    He S; Dong G; Cheng J; Wu Y; Sheng C
    Med Res Rev; 2022 May; 42(3):1280-1342. PubMed ID: 35001407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vivo synthetic chemistry of proteolysis targeting chimeras (PROTACs).
    Tomoshige S; Ishikawa M
    Bioorg Med Chem; 2021 Jul; 41():116221. PubMed ID: 34034148
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis targeting chimeras (PROTACs) for epigenetics research.
    Vogelmann A; Robaa D; Sippl W; Jung M
    Curr Opin Chem Biol; 2020 Aug; 57():8-16. PubMed ID: 32146413
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PROTACs- a game-changing technology.
    Konstantinidou M; Li J; Zhang B; Wang Z; Shaabani S; Ter Brake F; Essa K; Dömling A
    Expert Opin Drug Discov; 2019 Dec; 14(12):1255-1268. PubMed ID: 31538491
    [No Abstract]   [Full Text] [Related]  

  • 15. PROTAC-DB: an online database of PROTACs.
    Weng G; Shen C; Cao D; Gao J; Dong X; He Q; Yang B; Li D; Wu J; Hou T
    Nucleic Acids Res; 2021 Jan; 49(D1):D1381-D1387. PubMed ID: 33010159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PROteolysis TArgeting Chimeras (PROTACs) as emerging anticancer therapeutics.
    Khan S; He Y; Zhang X; Yuan Y; Pu S; Kong Q; Zheng G; Zhou D
    Oncogene; 2020 Jun; 39(26):4909-4924. PubMed ID: 32475992
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteolysis-targeting chimeras (PROTACs) in cancer therapy.
    Li X; Pu W; Zheng Q; Ai M; Chen S; Peng Y
    Mol Cancer; 2022 Apr; 21(1):99. PubMed ID: 35410300
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated Direct-to-Biology Platform for the Nanoscale Synthesis and Biological Evaluation of PROTACs.
    Stevens R; Bendito-Moll E; Battersby DJ; Miah AH; Wellaway N; Law RP; Stacey P; Klimaszewska D; Macina JM; Burley GA; Harling JD
    J Med Chem; 2023 Nov; 66(22):15437-15452. PubMed ID: 37933562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Proteolysis-targeting chimeras for targeting protein for degradation.
    Qi J; Zhang G
    Future Med Chem; 2019 Apr; 11(7):723-741. PubMed ID: 30706727
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beyond traditional methods: Unveiling the skin whitening properties of Rhein-Embedded PROTACs.
    Xu M; Zhang Z; Zhang P; Wang Q; Xia Y; Lian C; Liu J; Liu J
    Bioorg Med Chem; 2023 Dec; 96():117537. PubMed ID: 37992440
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.